Новости/Reuters/Cytokinetics stops development of ALS drugCytokinetics stops development of ALS drug31 мар. 2023 г.11:39 UTCCYTKCytokinetics Inc CYTK said on Friday it had stopped a late-study stage of its treatment for amyotrophic lateral sclerosis (ALS), as the drug was found to be ineffective.